Vertex Pharmaceuticals VRTX
CEO: Reshma Kewalramani · Biotechnology · 10,400 employees
C
Pay-for-Performance
59/100
$31.0M
CEO Total Comp
370:1
CEO-Worker Ratio
87.9%
Say-on-Pay Vote
+20.8%
3yr TSR
$84K
Median Worker Pay
Compensation Breakdown
Salary$1.4M
Stock Awards$20.0M
Options$5.5M
Non-Equity Incentive$4.1M
Other$106K
Compensation History
| Year | Salary | Bonus | Stock Awards | Options | Non-Equity | Other | Total |
|---|---|---|---|---|---|---|---|
| 2025 | $1.4M | — | $20.0M | $5.5M | $4.1M | $106K | $31.0M |
| 2024 | $1.3M | — | $18.3M | $6.0M | $1.9M | $120K | $27.6M |
| 2023 | $1.3M | — | $9.5M | $4.7M | $5.5M | $39K | $21.0M |
| 2022 | $1.3M | — | $12.3M | $5.8M | $4.7M | $158K | $24.2M |